top of page
Clinical experience and outcomes
No
Vector-related serious AEs reported
Real-world patients treated or in treatment (China program)
50+

It is important to note that the following data results depend on patient characteristics, baseline disease burden, and follow-up duration. Eligibility criteria, supportive care, and monitoring vary by center and region. Furthermore, any individual expectations should be discussed thoroughly with your treating physicians.
bottom of page


